3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Status Epilepticus: new trials by email Literature Review of Status Epilepticus trials Research Report on Status Epilepticus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Midazolam in Healthy Adults Midazolam, Seizalam - Status Epilepticus | Phase 1 | Completed | Rafa Laboratories | 40 | 2021-06-09 | 2022-03-17 |
| Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus SAGE-547 - Super-refractory Status Epilepticus | Phase 1 / Phase 2 | Completed | Supernus Pharmaceuticals, Inc. | 25 | 2014-03-21 | 2025-09-15 |
| Lorazepam for the Treatment of Status Epilepticus in Children lorazepam - Status Epilepticus | Phase 1 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 69 | 2005-03-01 | 2016-05-23 |
Nervous System Diseases (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Seizures (3) · Signs and Symptoms (3)
Lorazepam (1) · Midazolam (1) · brexanolone (1)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Rafa Laboratories (1) · Supernus Pharmaceuticals, Inc. (1)
United States (3)
James Chamberlain, MD (1) · Robert Lasser, MD, MBA (1)